HighMark Wealth Management LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$26,000
-27.8%
80,000
+60.0%
0.02%
-42.5%
Q2 2020$36,000
+176.9%
50,000
+25.0%
0.04%
+150.0%
Q1 2020$13,000
-90.3%
40,000
-79.2%
0.02%
-88.8%
Q4 2019$134,000–192,000–0.14%–
 Download
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 466$2,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders